Skip to content
646 269 0773|alita@globalbioethics.org
facebooktwitterlinkedin
Global Bioethics Initiative (GBI) Logo Global Bioethics Initiative (GBI) Logo Global Bioethics Initiative (GBI) Logo
  • Home
  • About
  • Staff
    • Founders
    • Board of Directors
    • Advisory Board
    • Visiting Scholars
    • Student Interns
    • Volunteers
  • Events
  • Resources
    • COVID-19
  • Internships
  • Contact
  • Donate
Previous Next
  • View Larger Image surgeons

Waiting for a New Face : The Transplants Giving People Back Their Lives

By Chiru Murage

Face transplants provide a new life for victims of horrific accidents, maulings, and violent crime. Because scars from such accidents can’t be hidden, face transplants give patients the ability to regain normality in their lives after a traumatic event. Since April 2014, there have been 28 face transplants around the world. Dr. Luskin, CEO of the New England Organ Bank, says “anyone with this disfigurement would argue they’re not living, they’re surviving.” The United Network of Organ Sharing “approved the first national policies for the transplantation of limbs, faces and other structures collectively known as ‘vascularized composite allografts’- which should make it easier to find donors.” Face transplants, like any other organ transplant, have specific requirements for the donor to match the recipient, such as hairline and race. “The likeliness of a perfect match can be challenging,” explains Dr. Eduardo Rodriguez, professor for reconstructive plastic surgery at NYU. The first face transplant was performed in 2005 in France on patient Isabelle Dinoire who survived a mauling by her dog. Since then the field has evolved to include hyper-modern technologies and has spread to six other countries. The growing operation has caused controversy in the world of organ donation, as people will be asked in the near future whether they would like to donate their faces after death. The risk of face transplant rejection is met with doubts from some who categorize a face transplant as live changing instead of life saving. Dr. Luksin, however believes “there is no ethical issue;” to him, the “point of these surgeries” is to see a “patient walking down a crowded hospital hall a few years after surgery and no-one [notices] him” because “he looks like a normal guy.”

For more information click here.

By Admin@gbi|2016-06-16T19:21:47+00:00August 11th, 2014|News-Articles|0 Comments

Share This Story, Choose Your Platform!

facebooktwitterlinkedinreddittumblrpinterestvkEmail

About the Author: Admin@gbi

Avatar

Related Posts

  • Call for Applications! Bioethics of AI: The Intersection of AI and Medicine” Online Winter School December 16-21, 2024
    Call for Applications! Bioethics of AI: The Intersection of AI and Medicine” Online Winter School December 16-21, 2024
    Gallery

    Call for Applications! Bioethics of AI: The Intersection of AI and Medicine” Online Winter School December 16-21, 2024

  • AI Ethics: Why it matters! by Adarsh Srivastava, PGDISAD, Head of Data & Analytics Quality Assurance at Roche Diagnostics
    AI Ethics: Why it matters! by Adarsh Srivastava, PGDISAD, Head of Data & Analytics Quality Assurance at Roche Diagnostics
    Gallery

    AI Ethics: Why it matters! by Adarsh Srivastava, PGDISAD, Head of Data & Analytics Quality Assurance at Roche Diagnostics

  • A Unique, Eye-opening experience: A physician’s perspective by Rola Itani, MD
    A Unique, Eye-opening experience: A physician’s perspective by Rola Itani, MD
    Gallery

    A Unique, Eye-opening experience: A physician’s perspective by Rola Itani, MD

  • Jonathan D. Moreno Ph.D. Keynote Speaker
    Jonathan D. Moreno Ph.D. Keynote Speaker
    Gallery

    Jonathan D. Moreno Ph.D. Keynote Speaker

  • Jeanne F. Loring Ph.D. Keynote Speaker
    Jeanne F. Loring Ph.D. Keynote Speaker
    Gallery

    Jeanne F. Loring Ph.D. Keynote Speaker

Copyright 2012 - 2020 Global Bioethics | All Rights Reserved | Powered by Global Innovation Consortium
facebooktwitterlinkedin
Toggle Sliding Bar Area